Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab mechanism-of-action study in psoriatic arthritis
2014-003148-11Phase 4Active
- Sponsor
- Academic Medical Center
- Start
- Jan 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ustekinumab in psoriatic arthritis (PsA), sponsored by Academic Medical Center. Primary endpoint: Change in synovial cellular and molecular pathways. Started Jan 2015; status: active.
02
Drugs
ustekinumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2014-003148-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003148-11.